+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence in Patient Engagement - Global Strategic Business Report

  • PDF Icon

    Report

  • 248 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6042645
The global market for Artificial Intelligence in Patient Engagement was valued at US$8 Billion in 2024 and is projected to reach US$23.1 Billion by 2030, growing at a CAGR of 19.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Artificial Intelligence in Patient Engagement Market - Key Trends & Drivers Summarized

How is AI Transforming Patient Engagement?

Artificial Intelligence (AI) is revolutionizing patient engagement by delivering personalized care, improving communication, and empowering patients to take an active role in their health management. Traditional patient engagement methods often rely on manual interactions and standardized approaches that fail to address individual needs effectively. AI addresses these challenges by leveraging machine learning (ML), natural language processing (NLP), and predictive analytics to create tailored and meaningful patient experiences.

AI-powered chatbots and virtual assistants provide 24/7 support, answering patient queries, scheduling appointments, and sending medication reminders. These tools enhance accessibility while reducing the administrative burden on healthcare providers. In addition, AI systems analyze patient data to offer personalized health recommendations, ensuring that engagement strategies align with individual preferences and medical histories.

Moreover, AI enhances patient education by delivering customized content through mobile apps, portals, and wearable devices. These platforms provide insights into health conditions, treatment options, and lifestyle changes, fostering informed decision-making. By enabling continuous and context-aware engagement, AI is transforming the way patients interact with healthcare services.

What Drives the Adoption of AI in Patient Engagement?

The growing demand for personalized and efficient healthcare experiences is a major driver of AI adoption in patient engagement. As patients increasingly seek customized care that addresses their unique needs, AI-powered solutions offer tailored communication and support that enhances satisfaction and outcomes. These tools cater to diverse patient preferences, from digital-savvy individuals to those requiring more guidance.

The rise of telemedicine and remote care models is also fueling AI adoption. With virtual consultations becoming more prevalent, AI-driven platforms bridge the gap by providing patients with tools for self-monitoring, symptom tracking, and virtual follow-ups. These capabilities ensure continuity of care while improving access for patients in remote or underserved areas.

Additionally, advancements in data integration and interoperability are enabling AI systems to provide seamless patient engagement across multiple touchpoints. By analyzing data from electronic health records (EHRs), wearable devices, and health apps, AI creates a unified view of the patient journey, ensuring consistent and impactful interactions. These trends underscore the growing importance of AI in reshaping patient engagement strategies.

Can AI Enhance Health Outcomes and Patient Satisfaction?

AI is significantly enhancing health outcomes and patient satisfaction by fostering proactive and personalized care. Predictive analytics tools identify patients at risk of chronic conditions or complications, enabling timely interventions and reducing the likelihood of hospitalizations. For example, AI systems monitor vital signs and lifestyle data to detect early warning signs of conditions such as diabetes or heart disease, allowing healthcare providers to take preventive action.

By automating routine tasks and improving care coordination, AI reduces administrative inefficiencies that often lead to patient dissatisfaction. Real-time updates, automated appointment reminders, and easy access to medical information empower patients to stay informed and engaged in their care. These capabilities enhance the overall patient experience while ensuring better adherence to treatment plans.

AI also supports mental health and well-being by providing tools for stress management, mindfulness, and behavioral therapy. Virtual mental health assistants deliver personalized recommendations and coping strategies, addressing the emotional aspects of patient care. These innovations contribute to holistic health management, improving both physical and mental well-being.

What's Driving the Growth of the AI in Patient Engagement Market?

The growth in the Artificial Intelligence in Patient Engagement market is driven by several critical factors, reflecting its transformative potential in healthcare. The increasing focus on patient-centric care models is encouraging healthcare providers to adopt AI tools that improve communication and deliver personalized experiences. These solutions help organizations build stronger relationships with patients, enhancing loyalty and trust.

Technological advancements in AI, including machine learning, NLP, and real-time analytics, are expanding the capabilities of patient engagement platforms. These tools provide actionable insights that enable healthcare providers to anticipate patient needs and deliver proactive support.

Consumer behavior trends, such as the growing preference for digital health solutions, are further driving market growth. Patients are embracing mobile apps, wearable devices, and virtual assistants as tools to manage their health effectively. Additionally, regulatory incentives promoting value-based care and patient engagement initiatives are supporting the adoption of AI in healthcare.

These factors, coupled with increasing investments in digital health technologies, are propelling the rapid expansion of the AI in Patient Engagement market, positioning it as a cornerstone of future innovation in healthcare delivery and patient-centric services.

Report Scope

The report analyzes the Artificial Intelligence in Patient Engagement market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Delivery Mode (Cloud-based Delivery Mode, On-Premise Delivery Mode); Functionality (Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality, Other Functionalities); Technology (Natural Language Processing (NLP) Technology, Other Technologies); Therapeutic Area (Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area, Other Therapeutic Areas); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Other End-Uses).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cloud-based Delivery Mode segment, which is expected to reach US$18.4 Billion by 2030 with a CAGR of a 21.7%. The On-Premise Delivery Mode segment is also set to grow at 12.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $2.1 Billion in 2024, and China, forecasted to grow at an impressive 18.3% CAGR to reach $3.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Artificial Intelligence in Patient Engagement Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Artificial Intelligence in Patient Engagement Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Artificial Intelligence in Patient Engagement Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Ada Health GmbH, AiCure, AllazoHealth, Claritas Rx, EmpiRx Health, LLC. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 52 companies featured in this Artificial Intelligence in Patient Engagement market report include:

  • Ada Health GmbH
  • AiCure
  • AllazoHealth
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • Innovaccer, Inc.
  • Medadvisor Solutions
  • Microsoft Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Economic Frontiers: Trends, Trials & Transformations
  • Artificial Intelligence in Patient Engagement - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Real-Time AI Chatbots Expand Opportunities for Enhancing Patient Communication
  • AI for Personalized Health Recommendations Strengthens Case for Proactive Engagement
  • AI-Driven Virtual Health Assistants Spur Growth in Home-Based Care Models
  • AI for Appointment Scheduling Optimizes Patient Flow, Driving Market Adoption
  • AI in Medication Adherence Monitoring Highlights Opportunities in Chronic Disease Management
  • AI-Powered Health Education Platforms Expand Addressable Market for Wellness Apps
  • Growing Demand for AI in Telehealth Sets the Stage for Patient-Centric Engagement Tools
  • AI for Remote Monitoring Systems Strengthens Case for Continuous Patient Interaction
  • AI for Multilingual Support Tools Bodes Well for Global Patient Engagement Markets
  • Integration of AI in Family Health Management Strengthens Use Cases in Collaborative Care
  • AI for Seamless Billing and Insurance Queries Drives Adoption in Revenue Cycle Management
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Artificial Intelligence in Patient Engagement Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 3: World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Cloud-based Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 5: World 6-Year Perspective for Cloud-based Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for On-Premise Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 7: World 6-Year Perspective for On-Premise Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 9: World 6-Year Perspective for Chronic Disease Management Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Health & Wellness Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 11: World 6-Year Perspective for Health & Wellness Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 13: World 6-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 15: World 6-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 17: World 6-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Enhanced Communication Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 21: World 6-Year Perspective for Enhanced Communication Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Chatbots & Virtual Health Assistants Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 23: World 6-Year Perspective for Chatbots & Virtual Health Assistants Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 24: World Recent Past, Current & Future Analysis for Predictive Analytics Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 25: World 6-Year Perspective for Predictive Analytics Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Patient Education Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 27: World 6-Year Perspective for Patient Education Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 29: World 6-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 30: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 31: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ada Health GmbH
  • AiCure
  • AllazoHealth
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • Innovaccer, Inc.
  • Medadvisor Solutions
  • Microsoft Corporation

Table Information